FDA Developments

Vinay Prasad Resigns as FDA Biologics Director After Politicized Tenure

His departure closes a brief tenure that saw him impose stricter COVID-19 vaccine guidelines under political scrutiny over a Duchenne muscular dystrophy gene therapy review.